1.WHO main website. https://www.who.int (accessed March 31th, 2020).
2.Coronavirus disease(COVID-19) Situation Dashboard. https://www.who.int/redirect-pages/page/novel-coronavirus-(covid-19)-situation-dashboard(accessed 7 June 2020)
3.Wu Z, McGoogan J M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. Jama, 2020, 323(13): 1239-1242.
4.Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. The lancet, 2020.
5.Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis[J]. International Journal of Infectious Diseases, 2020.
6.Cai H. Sex difference and smoking predisposition in patients with COVID-19[J]. The Lancet Respiratory Medicine, 2020, 8(4): e20.
7.Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2[Internet]. BioRxiv; 2020.Avaliable from:https://www.biorxiv.org/content/10.1101/2020.01.26.919985v2.full
8.Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov [Internet]. medRxiv; 2020. Avaliable from:
https://www.medrxiv.org/content/medrxiv/early/2020/02/17/2020.02.05.20020107.full.pdf
9.Wu J T, Leung K, Bushman M, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China[J]. Nature Medicine, 2020: 1-5.
10.Vardavas C I, Nikitara K. COVID-19 and smoking: A systematic review of the evidence[J]. Tobacco induced diseases, 2020, 18.
11.Nishiura H, Kobayashi T, Miyama T, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)[J]. [Internet]. medRxiv; 2020. Avaliable from:https://www.medrxiv.org/content/10.1101/2020.02.03.20020248v2
12.Corman V M, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR[J]. Eurosurveillance, 2020, 25(3): 2000045.
13.Pianosi P T, Zhang Z, Hernandez P, et al. Measuring dyspnea and perceived exertion in healthy adults and with respiratory disease: new pictorial scales[J]. Sports medicine-open, 2016, 2(1): 17.
14.Diagnosis and Treatment Plan for COVID-19 (Trial Version 6). Chin Med J(Engl) 2020 Mar 17.
15.Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis[J]. European Respiratory Journal, 2020.
16.Ouyang Y, Wang H, Su C, et al. Use of quantile regression to investigate changes in the body mass index distribution of Chinese adults aged 18-60 years: a longitudinal study. BMC Public Health. 2015;15:278. Published 2015 Mar 21. doi:10.1186/s12889-015-1606-8
17.US Department of Health and Human Services, and National Institutes of Health. Your guide to physical activity and your heart. No. 06-5714. NIH Publication, 2006.
18.Boon R M, Hamlin M J, Steel G D, et al. Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry[J]. British journal of sports medicine, 2010, 44(10): 741-746.
19.IPAQ committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). November 2005. Available from: http://www.ipaq.ki.se/scoring.html
20.Scholes S, Bridges S, Fat L N, et al. Comparison of the physical activity and sedentary behaviour assessment questionnaire and the short-form international physical activity questionnaire: an analysis of health survey for England data[J]. PloS one, 2016, 11(3).
21.National Sleep Foundation. National Sleep Foundation Recommends New Sleep Times. February 2, 2015).Available from https://www.sleepfoundation.org/press-release/national-sleep-foundation-recommends-new-sleep-times
22.Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19[J]. Jama, 2020, 323(14): 1406-1407.
23.Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China[J]. Science China Life Sciences, 2020: 1-6.
24.Lai C C, Liu Y H, Wang C Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths[J]. Journal of Microbiology, Immunology and Infection, 2020.
25.Choi S M, Jeong Y J, Park J S, et al. The impact of lifestyle behaviors on the acquisition of pandemic (H1N1) influenza infection: a case-control study[J]. Yonsei medical journal, 2014, 55(2): 422-427.
26.Cohen S, Doyle W J, Alper C M, et al. Sleep habits and susceptibility to the common cold[J]. Archives of internal medicine, 2009, 169(1): 62-67.
27.Jung S, Akhmetzhanov A R, Hayashi K, et al. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases[J]. Journal of clinical medicine, 2020, 9(2): 523.
28.Haskell W L, Blair S N, Hill J O. Physical activity: health outcomes and importance for public health policy[J]. Preventive medicine, 2009, 49(4): 280-282.
29.Gautret P, Lagier J C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial[J]. International journal of antimicrobial agents, 2020: 105949.
30.Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19[J]. Journal of critical care, 2020.
31.White D B, Lo B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic[J]. Jama, 2020, 323(18): 1773-1774.
32.Manca M, Rusticali F, Gaddi A, et al. Physical activity, exercise and cardiovascular health[J]. Future Lipidology, 2006, 1(5): 513-516.
33.Kokkinos P. Physical activity, health benefits, and mortality risk[J]. ISRN cardiology, 2012, 2012.
34.Wilde B E, Sidman C L, Corbin C B. A 10,000-step count as a physical activity target for sedentary women[J]. Research quarterly for exercise and sport, 2001, 72(4): 411-414.
35.Hills A P, Andersen L B, Byrne N M. Physical activity and obesity in children[J]. British journal of sports medicine, 2011, 45(11): 866-870.
36.Tuan T C, Hsu T G, Fong M C, et al. Deleterious effects of short-term, high-intensity exercise on immune function: evidence from leucocyte mitochondrial alterations and apoptosis[J]. British journal of sports medicine, 2008, 42(1): 11-15.
37.Blond K, Brinkløv C F, Ried-Larsen M, et al. Association of high amounts of physical activity with mortality risk: a systematic review and meta-analysis[J]. British journal of sports medicine, 2019: bjsports-2018-100393.